Burn-induced immunological modifications. Preliminary results with levamisole.
D000293:Adolescent; D000328:Adult; D000368:Aged; D002056:Burns / Q000150:complications / Q000188:drug therapy* / Q000276:immunology; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects; D007223:Infant; D007978:Levamisole / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D018805:Sepsis / Q000209:etiology; D014946:Wound Infection / Q000209:etiology
D007978:Levamisole